Additionally, SARS-CoV-2 infection can activate NF-κB, resulting in a "cytokine storm" that releases plenty of inflammatory factors, including IL-2, which in turn leads to lung damage in COVID-19 patients [45]. This evidence concerns the gene IL2 and COVID-19.